Outlook Therapeutics (OTLK) news
Recent news
Outlook Therapeutics highlights what the appointment of new CFO Kevin Lundquist means for the company’s next chapter in virtual investor discussion
AInvest Wire · Oct 6, 2026Outlook Therapeutics - On track for U.S. launch of Lytenava before year-end 2026
AInvest Wire · Oct 1, 2026Outlook Therapeutics - Lawrence Kenyon to step down as CFO effective September 1, 226
AInvest Wire · Aug 27, 2026S&P AFMS rtgs on Santander Holdings USA; OTLK still stable
S&P Global Ratings has revised its outlook for Santander Holdings USA, Inc. to negative from stable, reflecting evolving credit risks associated with the institution’s capital structure and strategic direction amid broader economic uncertainties [1]. The rating agency emphasized that while the bank…
AInvest Wire · Aug 21, 2026S&P downgrades pretzel parent to 'B-'; OTLK stable
S&P Global Ratings has downgraded Pretzel Parent Inc.’s issuer credit rating to 'B-' from a previous level, citing evolving credit conditions and operational performance . The downgrade reflects a reassessment of the company’s financial stability and capacity to meet long-term obligations. Despite…
AInvest Wire · Aug 18, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.